BioSpace News Archive

A commentary just published in Mayo Clinic Proceedings presents data showing no evidence linking refined grain consumption with risk of developing type 2 diabetes (T2D).

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), announced today the publication of positive efficacy and safety data from its completed B-SIMPLE 4 pivotal Phase 3 clinical study evaluating berdazimer gel, 10.3% for the treatment of molluscum in the peer-reviewed journal, JAMA Dermatology.

Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, recently had its Premarket Approval (PMA) Module II accepted and closed by the US Food & Drug Administration (FDA), an important milestone in the commercial approval process for its LimiFlex™ Dynamic Sagittal Tether™ (DST).

A sample of a new recombinant variant of SARS-CoV-2 virus, called Omicron XE, has been identified for the first time in the Miami-Dade area by a partner of AHF’s SARS-CoV-2 Genomic Sequencing Fund.

The global advanced wound care market size is expected to reach USD 16.85 Billion in 2030 and register a revenue CAGR of 6.7% over the forecast period, according to latest report by Reports and Data.

The global molecular diagnostics market size is expected to reach USD 50.94 Billion in 2030 and register a revenue CAGR of 12.4% over the forecast period, according to the latest report by Reports and Data.

The global robotic prosthetic market size is expected to reach USD 2,384.4 Million in 2028 and register a revenue CAGR of 8.9% over the forecast period, according to latest report by Reports and Data.

The global continuous glucose monitoring market was valued at US$ 992.8 Mn in 2022.

The global endoscopy devices market is expected to cross the value of US$ 42.8 Bn by the end of 2030.

The coronavirus pandemic has put intense strains on hospitals and clinics across the globe, both operationally & financially.